Paper16626889
FDG-PET/CT in the evaluation of anal carcinoma.
Cotter SE and 15 others. Int J Radiat Oncol Biol Phys, 2006. Cited by 129 papers, by iCite.
Cite this record
ConductScience Library. FDG-PET/CT in the evaluation of anal carcinoma. Papers, record 16626889. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16626889
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anus Neoplasms | Major topic |
| Fluorodeoxyglucose F18 | Major topic |
| Positron-Emission Tomography | Major topic |
| Radiopharmaceuticals | Major topic |
| Tomography, X-Ray Computed | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| HIV Seropositivity | |
| Humans | |
| Inguinal Canal | |
| Lymph Nodes | |
| Male | |
| Middle Aged | |
| Pelvis | |
| Retrospective Studies | |
| Survival Analysis |
Source PubMed
Cited by41
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42583203 | Neoadjuvant and adjuvant chemotherapy in anal cancer - is there a role in the future? | ESMO Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42583203 | PubMed |
| 40275508 | Pre-treatment tumour PET metrics and clinical outcomes of anal cancer in patients living with and without HIV. | Acta Oncol | 2025 | https://conductscience.org/library/papers/40275508 | PubMed |
| 38735904 | Updates on the Version 9 American Joint Committee on Cancer Staging System for Anal Cancer. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/38735904 | PubMed |
| 37592085 | [18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis. | Eur J Nucl Med Mol Imaging | 2023 | https://conductscience.org/library/papers/37592085 | PubMed |
| 35681647 | PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35681647 | PubMed |
| 34400269 | Long-Term Outcomes of NRG Oncology/RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Anal Canal Cancer. | Int J Radiat Oncol Biol Phys | 2022 | https://conductscience.org/library/papers/34400269 | PubMed |
| 34277406 | FDG-PET/CT in the Radiotherapy Treatment Planning of Locally Advanced Anal Cancer: A Monoinstitutional Experience. | Front Oncol | 2021 | https://conductscience.org/library/papers/34277406 | PubMed |
| 34259912 | Value of PET imaging for radiation therapy. | Strahlenther Onkol | 2021 | https://conductscience.org/library/papers/34259912 | PubMed |
| 33925282 | De-Escalation of Therapy for Patients with Early-Stage Squamous Cell Carcinoma of the Anus. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33925282 | PubMed |
| 33539412 | Use of advanced PET-volume metrics predicts risk of local recurrence and overall survival in anal cancer. | PLoS One | 2021 | https://conductscience.org/library/papers/33539412 | PubMed |
| 33531112 | Clinical Practice Guideline: Anal Cancer—Diagnosis, Treatment and Follow-up | Dtsch Arztebl Int | 2021 | https://conductscience.org/library/papers/33531112 | PubMed |
| 33256671 | Three-dimensional (3D) magnetic resonance volume assessment and loco-regional failure in anal cancer: early evaluation case-control study. | BMC Cancer | 2020 | https://conductscience.org/library/papers/33256671 | PubMed |
| 32884036 | Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients. | Sci Rep | 2020 | https://conductscience.org/library/papers/32884036 | PubMed |
| 32527039 | Prognostic Impact of Pretherapeutic FDG-PET in Localized Anal Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32527039 | PubMed |
| 30172447 | Multimodality Imaging Review of Anorectal and Perirectal Diseases With Histological, Endoscopic, and Operative Correlation, Part I: Anatomy and Neoplasms. | Curr Probl Diagn Radiol | 2019 | https://conductscience.org/library/papers/30172447 | PubMed |
| 30006428 | Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2018 | https://conductscience.org/library/papers/30006428 | PubMed |
| 29114593 | Quantitative FDG-PET/CT predicts local recurrence and survival for squamous cell carcinoma of the anus. | Adv Radiat Oncol | 2017 | https://conductscience.org/library/papers/29114593 | PubMed |
| 29089827 | Cancer of the Anal Canal: Diagnosis, Staging and Follow-Up with MRI. | Korean J Radiol | 2017 | https://conductscience.org/library/papers/29089827 | PubMed |
| 28972796 | PET imaging in anal canal cancer: a systematic review and meta-analysis. | Br J Radiol | 2017 | https://conductscience.org/library/papers/28972796 | PubMed |
| 27889036 | Diagnosis and Diagnostic Imaging of Anal Canal Cancer. | Surg Oncol Clin N Am | 2017 | https://conductscience.org/library/papers/27889036 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16626889
GET https://conductscience.org/api/papers/v1/16626889/cited_by?page=2